Parameters
|
FC
|
FT
|
R1 Female
|
MC
|
MT
|
R1 Male
|
---|
Albumin (g/dL)
|
3.06 ± 0.097
|
3.06 ± 0.030
|
2.6 – 3.4 a
|
3.03 ± 0.112
|
2.73 ± 0.042*
|
2.7 – 3.2 a
|
ALP (U/L)
|
48.00 ± 4.669
|
73.43 ± 5.622**
|
63 – 138 a
|
80.00 ± 4.889
|
109.4 ± 6.575**
|
79 – 196 a
|
TGP or ALT (U/L)
|
40.60 ± 3.614
|
51.57 ± 2.999*
|
26 – 60 a
|
68.43 ± 7.234
|
62.43 ± 2.653
|
36 – 58 a
|
TGO or AST (U/L)
|
106.80 ± 8.509
|
86.00 ± 5.499
|
83 – 184 a
|
160.9 ± 15.33
|
121.1 ± 14.12
|
81 – 180 a
|
Creatinine (mg/dL)
|
0.49 ± 0.007
|
0.5329 ± 0.015
|
0.4 – 0.7 a
|
0.59 ± 0.019
|
0.51 ± 0.007**
|
0.44 – 0.64 a
|
GLUC (mg/dL)
|
131.40 ± 7.593
|
161.7 ± 5.222**
|
61 - 147 a
|
157.6 ± 7.030
|
172.7 ± 7.819
|
79 – 144 a
|
K+ (mmol/L)
|
4.05 ± 0.193
|
4.06 ± 0.146
|
3.7 – 5.7 a
|
5.814 ± 0.370
|
5.07 ± 0.185
|
4.2 – 6.4 a
|
Na+ (mmol/L)
|
133.40 ± 0.812
|
134.10 ± 0.459
|
132 – 146 a
|
135.6 ± 1.478
|
135.3 ± 0.356
|
135 – 144 a
|
Total Protein (g/dL)
|
4.17 ± 0.063
|
4.27 ± 0.052
|
6.1 – 7.4 a
|
4.614 ± 0.230
|
3.81 ± 0.103**
|
5.4 – 6.6 a
|
TRIG (mg/dL)
|
32.75 ± 2.136
|
42.57 ± 3.683
|
39 – 130 a
|
46.57 ± 3.077
|
54.57 ± 6.294
|
42 – 160 a
|
Urea (mg/dL)
|
33.60 ± 1.503
|
37.14 ± 1.668
|
30 – 57 a
|
47.43 ± 1.251
|
37.57 ± 1.232
|
30 – 42 a
|
Uric acid (mg/dL)
|
1.65 ± 0.132
|
2.04 ± 0.169
|
1.2 – 2.5 a
|
3.37 ± 0.377
|
2.41 ± 0.298
|
0.9 – 2.0 a
|
Bil.IND (mg/dL)
|
0.08 ± 0.004
|
0.08 ± 0.003
|
0.01 – 0.01 a
|
0.07 ± 0.011
|
0.08 ± 0.003
|
0.01 – 0.01 a
|
D.Bil (mg/dL)
|
0.02 ± 0.004
|
0.02 ± 0.003
|
0.01 – 0.03 a
|
0.03 ± 0.011
|
0.02 ± 0.003
|
0.01 – 0.03 a
|
TBil (mg/dL)
|
0.10 ± 0.004
|
0.10 ± 0.003
|
0.07 – 0.09 a
|
0.10 ± 0.010
|
0.10 ± 0.003
|
0.07 – 0.09 a
|
CHOL (mg/dL)
|
60.60 ± 2.315
|
56.57 ± 2.599
|
55 – 79 a
|
59.57 ± 3.191
|
50.14 ± 2.405
|
46 – 101 a
|
-
FC (control female), FT (treated female), MC (control male), MT (treated male). N = 10. Data are expressed as mean ± S.D. * Indicate statistical difference between the control and treated group *p < 0.05, **p < 0.01 and ***p < 0.001 (test t). R1 (reference female); R2 (reference male); a Melo (2012).